Detection of gene amplification in MYCN, C-MYC, MYCL1, ERBB2, EGFR, AKT2, and human papilloma virus in samples from cervical smear normal cytology, intraepithelial cervical neoplasia (CIN I, II, III), and cervical cancer
HPV Amplification MYCN C-MYC MYCL1 ERBB2 EGFR AKT2
Article Sidebar
Main Article Content
Introduction: Cervical cancer is the second most common cancer among women worldwide and the second cause of cancer mortality in women. It has been demonstrated that the process of cervical carcinogenesis displays genetic and environmental epigenetic components. Currently, research is focused on new prognosis markers like oncogene amplification.
Objectives: To perform detection of MYCN, C-MYC, MYCL1, ERBB2, EGFR, and AKT2 amplification. Additionally, to detect human papillomavirus in samples from normal cytology smear, cervical intraepithelial neoplasia (CIN) I, II, and III and cervical cancer patients.
Methods: Papillomavirus (HPV) genotyping by reverse line blot (RLB) performed and gene amplification by detection with real-time PCR with Taqman probes.
Results: HPV was present in 4% of the patients with normal cytology, 48% in CIN I, 63.6% in CIN II, 64% in CIN III, and 70.8% in cervical cancer. Genes amplified in cervical cancer were MYCN (39.1%), ERBB2 (34.7%), and MYCL1 (30.4%); showed higher amplification in high-grade lesions and cervical cancer in relation to low-grade lesions and normal cytology with statistically significant differences. Besides the genes, C-MYC, EGFR, and AKT2 were amplified in samples from patients with cervical cancer by 12%, 18%, and 13%, respectively; we did not find statistical differences.
Conclusion: Higher prevalence of gene amplification and HPV was found in high-grade cervical lesions and cervical cancer.
Objectives: To perform detection of MYCN, C-MYC, MYCL1, ERBB2, EGFR, and AKT2 amplification. Additionally, to detect human papillomavirus in samples from normal cytology smear, cervical intraepithelial neoplasia (CIN) I, II, and III and cervical cancer patients.
Methods: Papillomavirus (HPV) genotyping by reverse line blot (RLB) performed and gene amplification by detection with real-time PCR with Taqman probes.
Results: HPV was present in 4% of the patients with normal cytology, 48% in CIN I, 63.6% in CIN II, 64% in CIN III, and 70.8% in cervical cancer. Genes amplified in cervical cancer were MYCN (39.1%), ERBB2 (34.7%), and MYCL1 (30.4%); showed higher amplification in high-grade lesions and cervical cancer in relation to low-grade lesions and normal cytology with statistically significant differences. Besides the genes, C-MYC, EGFR, and AKT2 were amplified in samples from patients with cervical cancer by 12%, 18%, and 13%, respectively; we did not find statistical differences.
Conclusion: Higher prevalence of gene amplification and HPV was found in high-grade cervical lesions and cervical cancer.
García, D. A., Briceño, I., Castillo, M., & Aristizábal, F. A. (2011). Detection of gene amplification in MYCN, C-MYC, MYCL1, ERBB2, EGFR, AKT2, and human papilloma virus in samples from cervical smear normal cytology, intraepithelial cervical neoplasia (CIN I, II, III), and cervical cancer. Colombia Medica, 42(2), 144–153. https://doi.org/10.25100/cm.v42i2.765
Downloads
Download data is not yet available.
- Consuelo Romero-Sanchez, Alberto Gomez-Gutierrez, Piedad Elena Gomez, María Consuelo Casas-Gomez, Ignacio Briceño, C677t (rs1801133 ) MTFHR gene polymorphism frequency in a colombian population , Colombia Medica: Vol. 46 No. 2 (2015)
- Korina María Rojas, Martha Roa, Ignacio Briceño, Carolina Guaneme, Alberto Gómez, Polimorfismos de 17 marcadores STR del cromosoma-Y en una muestra poblacional del altiplano cundiboyacense* , Colombia Medica: Vol. 42 No. 1 (2011)
- Mónica Díaz, Victoria Villegas, Clara López De Mesa, Diana Torres, Jaime Bernal, Alberto Gómez, Ignacio Briceño, Aplication of authenticity criteria in mitochondrial studies on archaic bone remains from a prehispanic Muisca population , Colombia Medica: Vol. 41 No. 4 (2010)
- Marta Bermúdez, Ignacio Briceño, Fabián Gil, Jaime Bernal, Homocisteína y polimorfismos de cistationina b sintasa y metilentetrahidrofolato reductasa en población sana de Colombia. , Colombia Medica: Vol. 37 No. 1 (2006)
- Dabeiba Adriana García, Yazmín Rocío Arias, Fabio Ancízar Aristizábal, Detection of genes mutations in the K-ras, H-ras and EGFR in samples of blood plasma and cervical smears for patients with cervical intraepithelial neoplasia III and cervical cancer , Colombia Medica: Vol. 40 No. 1 (2009)
Received 2011-06-13
Accepted 2011-06-13
Accepted 2011-06-13
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use